Articles tagged with Clinical Research
The study provides detailed structural information about LDL's main driver of cardiovascular disease. Researchers used advanced imaging techniques to visualize how LDL binds to its receptor, which could lead to new targeted therapies for high cholesterol and heart disease.
Researchers found significantly higher levels of p16INK4a in young people with sickle cell disease, indicating accelerated cellular aging. This discovery may lead to new treatments targeting cell aging and improved quality of life for SCD patients.
The 2025 Gottfried Wilhelm Leibniz Prizes were awarded to four female and six male researchers, with two working in the humanities and social sciences, four in life sciences, three in natural sciences, and one in engineering sciences. The winners received €2.5 million each to fund their research for up to seven years.
A $1.5 million grant will advance clinical testing of the noninvasive device in human participants with spinal cord injuries who experience AD. The device detects AD using sensors and controllers, measuring heart activity, skin nerve response, galvanic skin response, and skin temperature.
The American Heart Association has released its list of top cardiovascular research for 2024, focusing on prevention, treatment and the benefits of anti-obesity medications. The research highlights improvements in assessing cardiovascular risk, identifying early prevention opportunities and treating heart failure.
A study reveals that lower-income and minority mothers face disproportionate challenges in postpartum health due to inadequate social support systems. The research emphasizes the need for targeted policy interventions to improve maternal health equity, strengthen postpartum care, and reduce health disparities.
Research suggests that T-cell receptor repertoire analysis can inform treatment responses and predict efficacy in combination therapies for HCC. Advances in sequencing technologies are refining our understanding of tumor-immune interactions and adaptive immune mechanisms.
The collaboration aims to evaluate the potential of AMB-066 as a first-in-class treatment option for patients with colorectal cancer and minimal residual disease. MD Anderson researchers have identified a potential opportunity for AMB-066 to effectively treat MRD-positive CRC, based on robust preclinical data.
A study found that ADAMTS13 regulates VWF expression and reduces hepatic platelet accumulation in PA-ILI patients and mice. Systemic administration of recombinant ADAMTS13 decreased platelet accumulation and mitigated liver necrosis.
GLP-1RAs improve liver histology, reduce liver fat, and enhance metabolic parameters in MASLD patients. However, challenges remain in assessing long-term liver benefits and clarifying the effects on liver fibrosis.
Dr. Edo Ronald de Kloet shares insights on cortisol's dual role in protecting and damaging the brain through mineralocorticoid receptors (MR) and glucocorticoid receptors (GR). His discovery has transformed our understanding of stress-related mental disorders and led to novel therapeutic pathways.
A new gene therapy has reversed the effects of heart failure in a large animal model by increasing blood pumping efficiency and dramatically improving survival rates. The therapy restored critical functions of heart cells and improved heart function on the microscopic level.
Researchers at UCLA Health presented several breakthroughs at the San Antonio Breast Cancer Symposium, including improved survival rates for advanced breast cancer patients who receive trastuzumab deruxtecan (T-DXd), a novel ADC. Additionally, new genomic testing and circulating tumor DNA analysis may help identify high-risk patients a...
A new review published in Blood Cancer Discovery outlines how research supported a recent FDA committee decision to allow minimal residual disease as an endpoint for accelerated approval in multiple myeloma. This decision could cut a decade off the drug development process, enabling faster innovation in cancer treatment.
UCSF Medical Center has received the highest possible rating for maternity care, reflecting its commitment to clinical excellence and interdisciplinary collaboration. The hospital's maternal care teams include a broad array of expertise, including nurse practitioners, midwives, and obstetrician anesthesiologists.
A randomized clinical study found that an opioid-free treatment pathway is both safe and effective for bariatric surgery patients. The alternative method, which combines three different medicines, significantly reduces the need for opioids during treatment.
A new research paper published in Oncotarget introduces an innovative AI tool combining CT scans and body composition data to predict severe liver problems in primary sclerosing cholangitis (PSC) patients. The model achieved impressive results, correctly identifying at-risk patients with 97% accuracy.
The RATE-XR guideline standardizes reporting for early-phase clinical studies involving extended reality technologies, ensuring transparency, safety, and ethical reporting. Developed through a multidisciplinary team of international experts, the comprehensive framework fosters reproducibility and patient-centeredness.
Researchers are working to develop a curative treatment for multiple myeloma by combining treatments, overcoming resistance, and tailoring therapy to individual patients. The study found promising results using bispecific antibodies in combination with other treatments.
Researchers at Karolinska Institutet have identified two types of metabolic-associated fatty liver disease, a liver-specific type and a systemic type that affects other organs. The discovery could lead to improved diagnosis and treatment of this growing patient group, with potential benefits for cardiovascular health.
Dr. Aditya Bardia's appointment as Editor-in-Chief of Breast Cancer Research and Treatment reflects his expertise in targeted therapies and innovative research. He aims to foster innovation and disseminate knowledge benefiting patients and the scientific community through this journal.
Researchers develop personalized cognitive integrated sensorimotor virtual reality training to improve gait and balance in individuals with traumatic brain injury (TBI). A separate study uses robotic balance training combined with non-invasive brain stimulation to enhance postural control and motor recovery in TBI.
The University of Cincinnati College of Medicine has launched a styrofoam recycling project to divert over 900 pounds of EPS waste from landfills each month. The program aims to reuse existing styrofoam materials, reducing the need for styrene and minimizing environmental impact.
A systematic review of 45 studies found inconsistent descriptions of psychotherapy sessions, making it difficult to replicate studies and compromise patient well-being. Researchers call for improved reporting standards to enhance the replicability, safety, and potential effectiveness of these therapies.
Researchers have identified a promising new drug, lomonitinib, targeting treatment-resistant acute myeloid leukemia (AML) with FLT-3 mutation. Additionally, they developed a novel compound to target MALT1 protein in chronic lymphocytic leukemia (CLL), aiming to provide better control of the disease.
Researchers developed an interactive screening model called RITA-T, which improved early identification of high-risk toddlers from underserved areas. The study found that toddlers screened via RITA-T had shorter wait times and more accessible diagnostic services compared to those not using the model.
A study of 2,788 participants with impulse control disorder found that people with ICD are more likely to exhibit both overt and covert suicidal behavior. The study identified shared and specific risk factors for each type of behavior, including depressive symptoms and low self-direction.
Researchers observed a 100% response rate on Phase Ib trial for patients with newly diagnosed malignancy-associated hemophagocytic lymphohistiocytosis. Early intervention with ELA026 may provide meaningful clinical benefits for patients with few options.
Researchers at Lund University Diabetes Centre have mapped out differences in the atherosclerotic process in people with type 2 diabetes. The study found that high blood sugar levels can lead to reduced ability to form protective connective tissue in atherosclerotic plaques, increasing cardiovascular risk.
A new toolkit has been developed for clinicians involved in Child Death Review to improve support for bereaved parents. The recommendations include having a named bereavement support key worker within 24-48 hours after the child's death and providing training for healthcare professionals to better understand parents' roles.
A pilot clinical trial is testing the effectiveness of noninvasive electrical brain stimulation as a cognitive rehabilitation method for traumatic brain injury (TBI). The study aims to determine how early treatment with targeted brain stimulation can enhance cognitive recovery in moderate to severe TBI.
Three Texas A&M biologists have received NIH Maximizing Investigators’ Research Awards to support their research on type IV pili, darter fish social behaviors and bacteriophages. Drs Koch, Moran and Ramsey will explore bacterial behavior, genetic mechanisms and neural basis of paternal care in fish.
A study published in JAMA Network Open found that hospital-acquired pressure ulcers are associated with poorer neurological outcomes and reduced motor function in patients with acute cervical spinal cord injury. The findings suggest that preventing pressure ulcers can help protect these patients and lead to improved medical care.
Researchers at Wake Forest University School of Medicine found a strong association between living in disadvantaged neighborhoods and higher blood pressure and lower cognitive scores. The study analyzed data from over 500 adults aged 55+ and used the Area Deprivation Index to measure neighborhood disadvantage.
A study led by UF Health Cancer Center researchers found that a toxin in the bacteria Campylobacter jejuni accelerates the spread of colorectal tumors. The findings could lead to new tools for detecting metastatic colorectal cancer early, ultimately helping determine patients who need more aggressive treatments.
Researchers at Dana-Farber Cancer Institute have led three studies that provide new insights into treating acute myelogenous leukemia (AML) in various high-risk subtypes. The findings reveal that CPX-351 has a survival benefit for patients with AML-MR mutations, but may not be effective for those with TP53 or DDX41 mutations.
A study published in Nature Mental Health found that nearly half of young asylum seekers in the US exhibit worrisome symptoms of cardiovascular disease, including heart palpitations and chest pain. This unexpected prevalence highlights the need for clinicians to consider cardiovascular concerns when evaluating this younger population.
Pusan National University researchers have identified genes that are overexpressed in peri-implantitis, a condition similar to periodontitis but with higher recurrence rates. The study's findings may help diagnose and treat the disease with targeted therapies.
PCORI is inviting proposals for new patient-centered comparative clinical effectiveness research studies and projects offering over $500 million in potential funding. The organization aims to generate valuable insights to help people make better-informed healthcare decisions.
The PoweRD 2 Cure ALK+ Lung Cancer TeamLab aims to identify and exploit vulnerabilities of leftover cancer cells to prevent recurrence. By combining new strategies, structures, and thinking from across disciplines, researchers hope to develop treatment strategies that leave no cancer cells alive.
A new implantable device, inspired by a tree branch, uses DNA sensors to continuously monitor inflammation biomarkers in the body. The device accurately measures protein biomarkers of inflammation in diabetic rats and has potential applications for managing acute and chronic conditions.
A CU Anschutz study found that using a decision aid led to less personal uncertainty and distress among older adults, but not reduced depression. The online tool helped participants feel more confident in their decisions.
Researchers enhanced the Elixhauser Comorbidity Model to better predict key outcomes such as hospital length of stay, mortality, readmission, and escalated care. The improved model has broad implications for healthcare decisions and patient outcomes.
Researchers at MD Anderson Cancer Center presented findings on novel treatments for MDS, including luspatercept, which significantly reduced the need for blood transfusions in lower-risk patients. Additionally, a triplet therapy regimen improved survival in older adults with FLT3-mutated AML.
The Jackson Laboratory (JAX) has been awarded a $230,000 grant from the SynGAP Research Fund to characterize a mouse model for SYNGAP1-Related Disorders. This work aims to test innovative tRNA suppressor therapies and generate patient-derived research models.
Researchers at UCSF found a brain signature of resilience in mice that suggests a new way to treat severe depression. Stress changes activity in the amygdala, distinguishing resilient from less resilient mice. By stimulating neurons, the team improved decision-making and reduced ruminating in less resilient mice.
A team of researchers from Mass General Brigham has identified changes in immune cells that can predict patient recovery after cardiac arrest. The study suggests that a particular population of cells may provide protection against brain injury and a drug that can activate these cells, improving neurological outcomes in preclinical stud...
Researchers reported positive long-term results of bilateral capsulotomy for severe obsessive-compulsive disorder treatment, with high patient satisfaction even at 10 years. The study suggests MRgFUS capsulotomy may also be effective in managing other psychiatric diseases.
Researchers will test the hypothesis that environmental manganese exposure is associated with the progression of Parkinson's symptoms and measure neuroinflammation in the brain using MRI scans. The study aims to inform environmental regulations for manganese worldwide and address an environmental justice concern.
Research reveals African Americans have lower death rates after age 85 and up to age 100 compared to white populations. The study's lead author attributes this to psychosocial and biological factors that enable select survivors to withstand socioeconomic disadvantages.
A clinical trial led by University of Oklahoma Health Sciences is investigating a new device designed to restore ovulation in women with polycystic ovary syndrome (PCOS)-related infertility. The REBALANCE trial aims to assess the safety and effectiveness of the device, which uses electrothermal energy to prompt ovulation.
A new study proves a suspected link between poor sleep and MASLD, a liver disorder that affects 30% of adults. Patients with MASLD experience significant sleep fragmentation, waking up 55% more often at night.
A University of Arizona Health Sciences study found that peer support intervention improved CPAP adherence and patient satisfaction among 263 sleep apnea patients. The study showed that participants who received peer support used the CPAP machine correctly and consistently, averaging 4.5 hours of use per night, compared to those withou...
A new framework developed by UCLA researchers suggests that genetic data from large libraries of sequenced human genomes can improve the predictive power of genetics in determining how well a patient will respond to commonly prescribed medications and the severity of any side effects. The study, which analyzed data from over 342,000 pe...
Valentin Fuster, MD, PhD, has made significant contributions to the understanding of atherosclerosis through his research on inflammation, thrombosis, and treatment breakthroughs. His work has led to major advances in diagnosis and therapy, including the development of a cardiovascular 'polypill' that reduces cardiovascular mortality.
Researchers have found that B7-H4 helps ACC tumors evade the immune system, leading to poor survival outcomes. A new drug targeting B7-H4 showed promising results in shrinking tumors in aggressive cases.
Researchers at the University of Bonn are developing an AI foundation model to improve radiology and detect Parkinson's disease earlier. The 'Re-Start PD' project aims to identify the condition before symptoms appear, with potential applications in diagnosis, treatment, and prevention.
A scoping review found associations between myositis disease activity and gluten exposure in patients with inflammatory myopathies and celiac disease. The study suggests that gluten may act as an exogenous antigen driving myositis in genetically predisposed patients.
Researchers have identified UBA1 enzyme as key mediator for immune response to tumors, inhibiting its activity increases T-cell recruitment and lowers tumor resistance. Pairing UBA1 inhibitors with immune checkpoint blockade therapies may make immunotherapy more effective for patients with 'cold' tumors.
Mass General Brigham researchers presented research discoveries and outcomes from clinical trials on immune thrombocytopenia, early phase therapies, myeloproliferative syndromes, advances in treatment of lymphomas and leukemias. A novel prognostic score for relapsed/refractory mature T-cell and NK-cell lymphomas was also developed.